Postoperative Canadian Oral Anticoagulation Self-management (Post-COAGS) Trial

Hoffmann-La Roche

Overview

This study will measure the efficacy and safety of an early postoperative anticoagulation self-management program, using the CoaguChek S device, in patients undergoing mechanical valve replacements. Patients will be randomized into a study group (self-management) or a control group (physician management).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Conditions

Cardiovascular Abnormalities

Interventions

CoaguChek SDEVICE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * adult patients, 18-70 years of age; * recipient of a mechanical heart valve (aortic and/or mitral), +/- CABG, +/- postoperative atrial fibrillation. Exclusion Criteria: * recipient of a bioprosthetic valve; * post-operative thrombotic events; * pre-operative utilization of oral anticoagulation.

Locations (1)

Unnamed facility

Ottawa, Canada

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.